Delefilcon A multifocal contact lenses
DeviceMultifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)
Other names: DAILIES TOTAL1® multifocal
NCT Number: NCT02871375
The purpose of this study is to evaluate DAILIES TOTAL1® Multifocal (DTl MF) contact lenses in current multifocal contact lens wearers with symptoms of end of day discomfort compared to their habitual multifocal contact lens correction.
Looking for future studies?
Notify Me40 year–65 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)
Other names: DAILIES TOTAL1® multifocal
Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality
Time frame: Day 14, each product
Visual Acuity (clarity or sharpness of vision) was measured at high contrast level. HC/HI VA was assessed binocularly (both eyes together) at 80 centimeters using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart and measured in logarithm of the minimum angle of resolution (logMAR). A lower logMAR value indicates better visual acuity.
Time frame: Day 14, each product
The abbreviated CLDEQ-8 is an 8-item questionnaire used to assess comfort and dryness. Total CLDEQ-8 score ranged from 0 to 37, where a lower score represented less symptomology.
Alcon, a Novartis Company
Industry
DAILIES TOTAL1® Multifocal Clinical Assessment in Challenging Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial DetailsNCT05728944
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial DetailsNCT01322919
Eye Diseases, Hyperopia
Monterrey, N.l., Mexico
View Trial Details